Broad-spectrum antiviral activity of ebselen
Kunlakanya Jitobaom, Usa Boonyuen, Chompunuch Boonarkart, Thanyaporn Sirihongthong, Prasert Auewarakul · 2025
Read Broad-spectrum antiviral activity of ebselen by Kunlakanya Jitobaom, Usa Boonyuen, Chompunuch Boonarkart, Thanyaporn Sirihongthong, Prasert Auewarakul (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12749127.txt.
Description
Jitobaom and four co-authors reported this study in twenty twenty-five on a drug with wide antiviral reach. Broad drugs that work against many viruses are prized for pandemic readiness. The team tested ebselen, a lab-made compound that contains selenium. It was checked against dengue, Zika, chikungunya, flu, and a gut virus.
Ebselen blocked all five viruses in the lab. The authors traced much of its effect to one host enzyme, IMPA, which helps make a fat-like molecule that viruses need. Silencing the enzyme cut virus output. Adding back the missing molecule weakened the drug's effect. A second drug that blocks the same enzyme also worked broadly. The team names IMPA as a promising target for future antiviral drugs.
Catalog record
| CREATOR | Kunlakanya Jitobaom, Usa Boonyuen, Chompunuch Boonarkart, Thanyaporn Sirihongthong, Prasert Auewarakul |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |